Home › Products Liability › Programs & Materials

Programs & Materials

 

The documents below are written materials from programs that have been sponsored by the Products Liability Committee. Please note: You must be a Section of Litgation member and be logged in to access the files.

All files are available in PDF format unless otherwise noted. ()

Chemical & Industrial Products Regional CLE Workshop: October 2011—Wilmington, DE

• » Meeting Brochure
• » ABA Panel Pre-Settlement Considerations
• » A Cohort Mortality Study Among Gas Generator Utility Workers
• » The Question of Causation: Does Science Have an Admissible Answer?
• » Assessing Causality in Observational Research
• » Mediation Day: Key Elements for Success
• » Strategic Jury Selection: Limiting Mistakes in a Difficult Process
• » The Appeal of Junk Science
• » The Risks of "Attacking the Plaintiff"

Food & Supplements First Annual Workshop: February 2011—Atlanta, GA

• » FDA's Changing Approaches to Food Recalls—Implications for Industry and Litigators
• » A New Frontier: Health-Claims Class Actions
• » Strict Liability in Food-Borne Illness Cases
• » Ethical Considerations in the Labeling of Biologically Active Foods
• » In-House Counsel's Top Predictions for the Future of Food Regulation and Litigation

Environmental, Mass Torts and Products Liability CLE Seminar: Avon, CO – January 2010

• » View Full List of Program Materials

Section of Litigation Joint CLE Seminar: January 2009 (Vail, CO)

• » Products Liability 2008: A Year in Review
• » Working with Experts 101: The Do's and Don'ts Every Young Lawyer Should Know

•  In-House Counsel On Guard — Innovative Methods for Managing High-Stakes Litigation
• » Case Study: Georgia-Pacific’s Aggressive Use of Early Case Evaluation and ADR
• » Georgia-Pacific’s ADR Program: A Critical Review After 10 Years
• » Corporations Spend More on In-House Lawyers, Less on Outside Firms
• » Outside Law Firms Still Don’t Get It, In-House Counsel Say in Survey
• » Some Lawyers Are Reducing Fees, as Corporations Seek Discounts
• » Will Corporate Counsel Push Law Firms to Drop Hourly Billing?



• » View Full List of Program Materials

Section of Litigation Joint CLE Seminar: January 2008 (Snowmass, Co)

• » View Full List of Program Materials

Women in Products Liability: October 2007 (New Orleans, LA)

• » Program Materials and Panel Bios
• » Corporate Witness Depositions: Practical Tips and Guidelines
• » Kroll Ontrack: Electronic Discovery and Computer Forensics Case Law
• » Kroll Ontrack: Electronic Discovery and Computer Forensics Case List
• » The Million Dollar Question: How Can You Control E-Discovery Cost?
• » The ESI Revolution: Preparing for E-Discovery in Light of the New Federal Rules
• » Panel Groups, Trial Simulations and Selecting a Products Liability Jury
• » Special Report on Women and Minorities in the Profession
• » Courtoom Triage: Bayer, Pressed to Settle a Flood Of Suits Over Drug, Fights Back
• » Seven Habits of Successful Rainmakers
• » You Can Have it All – If You Know What “All” it is You Want
• » We're Outta Here: Why Women Are Leaving Big Firms
• » Balancing Law and Motherhood: One Woman’s Experience
• » What You Need to Know About Mentoring the New Generations

Biotech Regional Workshop: October 2007 (San Francisco, CA)

• » The Duties of Sponsors and Investigators in Clinical Trials
• » Managing Collaboration Agreements and Handling Issues Arising From Them
• » Recall and Other Tough Calls (Crisis Management Issues)
• » Potential Liability Issues in Personalized Medicine
• » Risk Management of International Clinical Trials

Chemical Products Liability Regional Workshop: September 2007 (Wilmington, DE)

• » Download Full Materials Packet (17 MB)

Automotive Regional Workshop: June 2007 (Detroit, MI)

• » “We Intend to Preempt”—Developments in Preemption by Safety Agency Regulation
• » New Electronic Witness: EDRs in Motor Vehicles
• » E-Discovery: The First 180 Days

Section Annual Conference: April 2007 (San Antonio, TX)

• » Visually Projecting Your Winning Arguments: Using Graphics to Persuade
• » Different Venues, Different Verdicts: Cynthia R. Cohen
• » Different Venues, Different Verdicts: Richard F. Scruggs and David W. Shelton

Joint CLE Seminar: January 2007 — Products Breakout Session Materials

• The Good, the Bad and the Ugly
• » Product Liability Year In Review (Mark Herrmann)
• » Product Liability Year In Review (N. Karen Deming)

• The FDA at 100: A Look Back and a Look Ahead
• » The Future of Drug Safety: Action Steps for Congress
• » The FDA’s Reputation with the General Public is Under Assault
• » Manual of Policies and Procedures: Center for Drug Evaluation and Research
• » The Food and Drug Administration’s Regulation of Risk Disclosure for Implantable Cardioverter Defibrillators

• » View all materials from the 2007 Joint CLE Seminar

Pharmaceutical Regional CLE Workshop: November 2006 (Kenilworth, NJ)

• Government Investigations Into Allegations of Off-Label Marketing
• » Panel Discussion Materials

• Presenting the FDA Defense in Light of Changing Juror Perspectives
• » Case Overview
• » The FDA Halo Collapse: Effective Trial Strategies to Address Jurors’ Declining Perception of the FDA in Pharmaceutical Product Liability Cases. Rx for the Defense 2006; 34-37. Livingston JE, Blout A.
• » Determining Juror Perceptions of the FDA that Affect Verdicts in Pharmaceutical Lawsuits. Cohen CR.

• Beyond The Preemption Preamble: A Practical Analysis of the New FDA Labeling Requirements
• » The FDA’s “Preemption Preamble” – Defense Perspective
• » Federal Register.  Part II: Department of Health and Human Services, FDA. January 24, 2006.
• » Questions and Answers About the New Content and Format Requirement for Prescribing Information
• » FDA Announces Final Rule on the Requirements for Prescribing Information for Drug and Biological Products

• The Increasing Attempts to Use U.S. Courts by Foreign Plaintiffs
• » Abdullahi v. Pfizer, Inc. S.D.N.Y., 2005 Westlaw citation
• » Adamu v. Pfizer, Inc. S.D.N.Y., 2005
• » In re Factor VIII or IX Concentrate Blood Products Liability Litigation. Dominico Gullone, et al., v. Bayer Corporation, et al., M.D.L., 2006
• » Defendants’ Amended Forum Non Conveniens Statement. Domenico Gullone, et al., vs. Bayer Corporation, et al.
• » Order & Reasons.  Inre Products Liability Litigation
• » Memorandum of Decision on Motion, Pursuant to Rule 1:6-2(f)
• » Tuazon v. R.J. Reynolds Tobacco Co.

Biotech Regional CLE Workshop: October 2006 (Cambridge, MA)

• » Trusting Doctors: Tricky Business When It Comes to Clinical Research
• » Changes in Patent Rules Implications for Your Company's Patent Strategy
• » New Prescription Drug Labeling Rule and Its Preamble: Their Impact on Product Liability Litigation
• » The New Rx Drug Labeling Rule and Its Impact on Product Liability Litigation
• » Risk Management of Clinical Trials
• » Collaborative Agreements: The Trial Lawyer's Perspective on Managing Relationships
• » Emerging IP Issues
• » Recall and Other Tough Calls (Crisis Management Issues)

Contamination Examination Regional CLE Workshop: September 2006 (Wilmington, DE)

• » Emerging Issues and Recent Developments in Chemical and Products Liability Law
• » Discovering the New Frontier: Discovery Management in the Age of New Science and New Legal Theories
• » A Brave New World: The Enforcement of Foreign Judgments in the United States
• » For Better or Worse: The Rocky Marriage between Administrative Agencies and Civil Litigation
• » Exposing Exposure: Developing Novel Theories of Recovery in Toxic Tort Litigation

Women in Products Liability: September 2006 (Las Vegas, NV)

• » Program Materials and Panel Bios
• » Where I Lead, You Will Follow
  Ann Farmer
• » Not Much to Gain?
  Mary A. Zambreno
• » Early Exits
  Jill Schachner Chanen
• » Focus on Diversity
  DuPont Plays a Leadership Role

ABA Annual Meeting: August 2006 (Honolulu, HI)

• » Test-Driving Your Trial Strategy: Crossing the Finish Line First
  Cynthia R. Cohen, Ph.D.
• » Fact Pattern
• » Plaintiff Powerpoint Slides
• » Defendant Powerpoint Slides

Current Issues in Medical Device Litigation: June 2006 (Forth Worth, TX)

• » Outline for Discussion of Recent Developments in Medical Device Litigation
  Neville H. Boschert
• » Recent Developments in Medical Device Law
  Sherry A. Knutson
• » Regulatory Update: Current Issues in Medical Device Litigation
  Michael Morton, Michael Pfledger, Ginger Heyman Pigott
• » The Litigation Fallout from a Device Recall: What You Can Say Can Be Used Against You
  Timothy A. Pratt
• » Causation: An Epidemiologic Perspective (In Five Parts)
  Douglas L. Weed, M.D., Ph.D.
• » Medical Monitoring
  Kelly S. Witte
• » New FDA Regulations for Labeling for Prescription Drug Products
  Kelly S. Witte
• » Proposed Amendments To The Federal Rules of Civil Procedure

Publications

• » Update on Punitive Damages Claims: A 50-State Survey
  State authors discuss the recent development of laws in their states and how they impact general and pharmaceutical litigation.
• » The Use of Toxicology in Tort Litigation
  This monograph surveys the use and treatment of toxicological evidence in each federal circuit and courts in all 50 states.
• » Post-Sale Duty to Warn
  This survey provides a comprehensive summary of current U.S. common law on post-sale responsibilities.